| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/21/2011 | EP2366702A1 New oxadiazole derivatives |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366695A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 09/21/2011 | EP2366691A1 The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof |
| 09/21/2011 | EP2366690A1 Salts and crystalline salt forms of an 2-indolinone derivative |
| 09/21/2011 | EP2366689A1 Saccharin salts and crystalline salt forms of an 2-indolinone derivative |
| 09/21/2011 | EP2366688A1 Salts and crystalline salt forms of an 2-indolinone derivative |
| 09/21/2011 | EP2366687A2 Benzenesulfonamide derivatives and pharmaceutical composition thereof |
| 09/21/2011 | EP2366684A1 New compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method |
| 09/21/2011 | EP2366400A1 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine |
| 09/21/2011 | EP2366398A1 Cancer therapy with a parvovirus combined with an HDAC inhibitor |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365987A1 Isoform specific anti-her4 antibodies |
| 09/21/2011 | EP2365955A1 Aryl di-substituted propenone compounds |
| 09/21/2011 | EP2365828A2 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 09/21/2011 | EP2365815A2 Extracellular matrix compositions for the treatment of cancer |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2351764A8 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/21/2011 | EP2134346B1 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| 09/21/2011 | EP2045258B1 3'-ethynylcytidine derivative |
| 09/21/2011 | EP1971338B8 Combination of zd6474 and pemetrexed |
| 09/21/2011 | EP1966202B1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 09/21/2011 | EP1873204B1 Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| 09/21/2011 | EP1802339B1 Treating neoplasms with neurotoxin |
| 09/21/2011 | EP1773854B1 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 09/21/2011 | EP1771413B1 Benzofuran derivatives as selective androgen receptor modulators (sarms) |
| 09/21/2011 | EP1751171B1 Novel galactoside inhibitors of galectins |
| 09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | EP1385993B8 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 09/21/2011 | EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | EP0725791B1 Recombinant p53 adenovirus methods and compositions |
| 09/21/2011 | CN1952129B Angptl4 deletion mutant and application thereof |
| 09/21/2011 | CN1927883B Novel cytokine zalpha11 ligand |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN1723984B Medicine for inducing cells to die, and its application |
| 09/21/2011 | CN102197131A Elimination of a contaminating non-human sialic acid by metabolic competition |
| 09/21/2011 | CN102197035A Novel crystalline form and processes for its preparation |
| 09/21/2011 | CN102197034A Novel polymorphs of sunitinib and processes for their preparation |
| 09/21/2011 | CN102197032A Heterocyclic PIM-kinase inhibitors |
| 09/21/2011 | CN102197030A Rotaxane compound and antitumor agent |
| 09/21/2011 | CN102197029A Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine |
| 09/21/2011 | CN102191310A Application of miRNA (micro Ribonucleic Acid) related to sensitivity to camptothecin medicaments |
| 09/21/2011 | CN102191271A Anti-tumor recombinant plasmid as well as gene vaccine, preparation method and application thereof |
| 09/21/2011 | CN102191246A Multi-target interfering nucleic acid molecule and application thereof |
| 09/21/2011 | CN102191244A Group of siRNA molecules capable of effectively reducing PRDM1beta expression and application thereof |
| 09/21/2011 | CN102191224A Heavy targeted modification method for herpes simplex viruses and application thereof |
| 09/21/2011 | CN102191183A Morchella submerged fermentation production process |
| 09/21/2011 | CN102190729A Anti-human CD80 bivalent dimer and application thereof |
| 09/21/2011 | CN102190728A Novel humanized anti-CD20 monoclonal antibody |
| 09/21/2011 | CN102190718A Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 09/21/2011 | CN102190713A Synthetic peptide and application thereof |
| 09/21/2011 | CN102190684A Phosphorus-containing compound having drug actions, and preparation and application thereof |
| 09/21/2011 | CN102190669A Dihydro pteridinone derivatives, preparation method thereof and application thereof in medicines |
| 09/21/2011 | CN102190668A Quinazoline-2(1H)pyridinethione derivatives, and medicinal composition, preparation method and application thereof |
| 09/21/2011 | CN102190663A Crystal form of Dimethylamino Arglabin hydrochloride |
| 09/21/2011 | CN102190658A Structural analogue of antineoplastic marine natural product ecteinascidins |
| 09/21/2011 | CN102190645A Osthole derivative, its preparation method and its application in preparing medicine for treating breast cancer |
| 09/21/2011 | CN102190644A Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof |
| 09/21/2011 | CN102190643A Antitumoral compounds |
| 09/21/2011 | CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs |
| 09/21/2011 | CN102188724A Novel ultrasonic quick-release preparation for radiotherapy of tumor in vivo, and preparation method thereof |
| 09/21/2011 | CN102188719A Application of EB virus miR-BART3 antisense oligonucleotides in preparing medicament for treating nasopharyngeal darcinoma |
| 09/21/2011 | CN102188718A Application of micromolecule RNA has-miR-29c in preparing medicine treating liver cancer |
| 09/21/2011 | CN102188717A Self-emulsifying doxorubicin nanometer medicament and preparation method thereof |
| 09/21/2011 | CN102188716A Macromolecule vinblastine conjugate adopting amino acids or oligopeptides as connexons |
| 09/21/2011 | CN102188713A Liver targeting pharmaceutical composition and its preparation method |
| 09/21/2011 | CN102188705A Medicament composition containing bis cyclooctane derivatives |
| 09/21/2011 | CN102188704A Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 09/21/2011 | CN102188698A Combination of ribonuclease and artemisinin |
| 09/21/2011 | CN102188667A Novel Chinese traditional medicine for treating cancer |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188644A Traditional Chinese medicine for treating cancers |
| 09/21/2011 | CN102188638A Medicament for treating liver cancer |
| 09/21/2011 | CN102188620A Method for extracting total Dendrobium alkaloids from Dendrobium nobile Lindl waste residue |
| 09/21/2011 | CN102188590A Zengshengping dispersing tablet composition and preparation method thereof |
| 09/21/2011 | CN102188589A Zengshengping oral liquid composition and preparation method thereof |
| 09/21/2011 | CN102188588A Hyperplasia relieving granule composition and preparation method thereof |
| 09/21/2011 | CN102188587A Zengshengping effervescent tablet composition and preparation method thereof |
| 09/21/2011 | CN102188564A Typhonium giganteum supercritical extract with anticancer activity and preparation method thereof |
| 09/21/2011 | CN102188557A Application of Juncus effuses L. extract in preparing anti-tumor or angiogenesis-inhibiting medicament, health food or cosmetic |
| 09/21/2011 | CN102188543A Tea polyphenol tablet and preparation method thereof |
| 09/21/2011 | CN102188507A Composition possessing antineoplastic function, its preparation method and application |
| 09/21/2011 | CN102188502A Extraction method and composition of common souliea rhizome total saponins with anti-tumor effect |
| 09/21/2011 | CN102188501A Rhubarb anthraquinones component extracting and separating method |
| 09/21/2011 | CN102188489A Composition containing fructus broussonetiae extract for strengthening immune function |
| 09/21/2011 | CN102188467A Traditional Chinese medicine composition for reinforcing vital energy and consolidating constitution, boosting human immunity, resisting fatigue and tumor, and delaying aging |
| 09/21/2011 | CN102188459A Brucea javanica total terpenoid extractive, and preparation method and application thereof |
| 09/21/2011 | CN102188457A Scientific treatment method for cancer and broad-spectrum medicament for curing cancer |
| 09/21/2011 | CN102188446A Application of adult stem cells in treating malignant solid tumors |
| 09/21/2011 | CN102188439A Nanoparticle liposome for releasing different medicines in programmed manner and preparation and use thereof |
| 09/21/2011 | CN102188424A Anti-leukemia effects of SR140333 |
| 09/21/2011 | CN102188418A Application of salinomycin in preparing medicament for resisting various human malignant tumors |
| 09/21/2011 | CN102188415A Method of treating cancer with HDAC inhibitors |
| 09/21/2011 | CN102188403A Cucurbitacin capsules and preparation method thereof |
| 09/21/2011 | CN102188394A Vinflunine freeze-drying medicinal composition |